PHARMACEUTICAL SERVICES

meet us at
Oct. 25th - 27th - 2011
CPHI Frankfurt - Germany
March 12th - 15th - 2012
DCAT New York - USA

LAST NEWS
2011 - Certificate of GMP compliance of a Manufacturer for Human investigational medicinal product

2011 - Certificate of GMP compliance of a Manufacturer for Human medicinal product

MAA CESSION & TRANSFER
Licensing-out opportunity Cetirizine 10 mg/ml, oral solution (NL33352)
NEW MAA CESSION & TRANSFER
Licensing-out opportunity Donepezil 5 mg, ODT (NL37771) and Donepezil 10 mg, ODT (NL37772)
2009 - cGMP Agreement for human use

Galenix Pharma has obtained an updated agreement for cGMP manufacturing, importation and ditribution of human and investigational medicinal products AFSSAPS #M09/168
2008 - cGMP Agreement for veterinary use

Galenix Pharma has obtained an agreement for cGMP manufacturing, importation and distribution of veterinary and investigational medicinal products AFSSA #V1515/08
MAA CESSION & TRANSFER
Licensing-out opportunity Fenofibrate 67 mg, tablet (NL27271) - Fenofibrate 200 mg, tablet (NL27274) and Fenofibrate 160 mg, modified release tablet (NL31360)

newsletter signup
Subscribe Newsletter Please insert your email adress


indentification user
Forgot password Register

With more than 15 years of experience, the Regulatory affairs is in charge of the documentation required for registration of drug substances, clinical trials and drug products:
- European and US DMF
- IMPD, pre-IND meeting, IND, etc...
Marketing Authorization Application C.T.D., ANDA, NDA, compiling and Submission on customer's behalf or Galenix's

The Regulatory affairs also Coordinates Phase I clinical studies in partnership with more than 10 C.R.O. in Europe and worldwide, bioanalysis and toxicology laboratories
Galenix Pharma facilities
Home - About us - Pharmaceutical Services - Clinical Supplies - Drug delivery - Business Opportunities - News - Job offers - Contact
Copyright © 2010 Galenix - Tous droits réservés